Our History
Establish Hangzhou branch to expand international business.
Launch international certification comprehensively. Comprehensively launched the international certification work.
Obtain government approval of Shitang Road Site.
Submit the 1st DMF to FDA.
Establish Xiamen branch for domestic marketing.
Shitang Road Site (Hunan Runxing Pharmaceutical Co., Ltd) put into production, with annual capacity 3000MT
Establish industry-university-research cooperation with the College of Chemistry and Chemical Engineering of Hunan University
Awarded the "Hunan Provincial Enterprise Technology Center"
Cooperate with Pfizer Inc. and Thermo Fisher Scientific, which are Top-10 pharmaceutical innovation enterprises in the world
Achieved the production of HOPO, the company's first self - developed product with a capacity of 100 tons--> Achieve 100MT-production of our 1st self-developed product HOPO
Obtained the government approval of the first API- Olmesartan Medoxomil
Establish cooperation with Abbvie, one of the Top-10 pharmaceutical innovation enterprises in the world
Obtain the Drug Production License
Establish industry - university - research cooperation with Changsha University
Establish a wholly - owned subsidiary "Hunan Runxing Pharmaceutical Co., Ltd." (Shitang Road Production Base)
Name changed to be "Hunan Eurasia Pharmaceutical Co., Ltd."
Complete the transformation of API workshops and achieve the enterprise transformation
Awarded as "Hunan Provincial Little Giant Enterprise"
Enter into overseas market and start cooperation with well-known pharmaceutical enterprises in Europe and India.
Awarded as ‘Changsha Innovative Unit’.
Obtained the qualification of National High - tech Enterprise
Awarded as ‘Changsha Enterprise Technology Center’
Awarded "Science and Technology Innovation Award" of Hunan Province
The company was registered and established
